echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > [quick news] on October 26, 2018, FDA approved the new mechanism of anti influenza drugs to be launched

    [quick news] on October 26, 2018, FDA approved the new mechanism of anti influenza drugs to be launched

    • Last Update: 2018-10-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the new mechanism of anti influenza drugs approved by the FDA came into the market Recently, the US FDA announced the approval of xofluza (baloxavir marboxil), a new anti influenza drug jointly developed by Shionogi and Roche of Japan, for the treatment of acute influenza patients over 12 years old without complications This is the first new anti influenza drug with innovative mechanism approved by FDA in recent 20 years The mechanism of xofluza is different from that of antiviral therapy It can inhibit the replication of influenza virus by inhibiting cap dependent endonuclease Https:// Tongji University found that the CGAs enzyme, known as CGAs, is a DNA recognition receptor It was first identified by Professor Chen Zhijian, a famous Chinese scholar in the United States It is a milestone in the field of DNA recognition and innate immunity The synthetase can promote the production of type I interferon and immune factors Ge Baoxue, Professor of Medical College of Tongji University, and Mao Zhiyong, Professor of life science and Technology College of Tongji University, worked together to systematically explain for the first time the new functions of CGAs in the nucleus that are completely independent of DNA recognition function, providing a theoretical basis for the development of new anti-tumor drugs based on the intervention of CGAs into the nucleus Recently, this important research result was published online in nature Https:// the round table meeting of China, Japan and South Korea Academy of engineering focuses on "the new generation of artificial intelligence" Recently, the 21st round table meeting of China, Japan and South Korea Academy of engineering and the International Symposium on the new generation of artificial intelligence were held in Deqing, Zhejiang Province The theme of this session is "a new generation of artificial intelligence" Experts and scholars present at the meeting made special reports on intelligent manufacturing, intelligent medical care, intelligent economy and other topics Li Lanjuan, academician of the Chinese Academy of engineering, pointed out that the application of artificial intelligence technology in the field of medical health has always been regarded as an important direction of the development of artificial intelligence The development of artificial intelligence technology in the field of medical health can improve the supply capacity of medical services, improve the accuracy of medical services, realize the standardization and quality control of medical services, and promote the development of medical health related industries Http://news.scienceet.cn/htmlnews/2018/10/419113.shtm scientists find the "regulating switch" of brain sleeping and waking Recently, science magazine published the research results of Professor Hu Zhian's research group entitled "paraventricular nucleus of thalamus is the key nucleus to maintain arousal in thalamus" It is the first time to confirm that paraventricular nucleus of thalamus is the key brain area to maintain arousal, and to clearly reveal the neural loop mechanism of paraventricular nucleus of thalamus to maintain arousal "The paraventricular nucleus controls the nucleus accumbens and induces the transition from sleep to wake." Hu said the findings have important potential clinical significance Http://science.sciencemag.org/content/362/6413/429 "super life computer" of Huada group has recently come Huada Zhizao, a subsidiary of Huada group, has released the latest ultra high throughput gene sequencer independently developed by itself Restricted by the number, speed and cost of equipment and other practical reasons, the efficiency of genome sequencing has not been promoted smoothly in the past few years The latest high-throughput gene sequencer "mgiseq-t7" released this time is likely to change this situation It can complete the whole genome sequencing of 60 individuals in one day, and six machines can complete the genome sequencing of 100000 people in one year It is the most powerful gene sequencer in the world, so it is called "super life computer" http://digitalpaper.stdaily.com/http_
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.